# D-amino Acid Oxidase Inhibition (DAAOI-1) add-on Treatment for Chronic Schizophrenia

> **NCT00960219** · PHASE2 · COMPLETED · sponsor: **China Medical University Hospital** · enrollment: 52 (actual)

## Conditions studied

- Schizophrenias
- Psychoses
- Psychotic Disorders
- Schizophrenic Disorders

## Interventions

- **DRUG:** D-amino acid oxidase inhibition (DAAOI-1)
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00960219
- **Lead sponsor:** China Medical University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2011-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00960219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00960219, "D-amino Acid Oxidase Inhibition (DAAOI-1) add-on Treatment for Chronic Schizophrenia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00960219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*